Our findings support the notion that SRC activation may contribute to metastatic dissemination in HNSCC [25] and provide additional evidence extending the association of SRC activation with EMT to other HNSCC subtypes (i.e., laryngeal and pharyngeal carcinoma) beyond previous observations in nasopharyngeal carcinoma [56]. This evidence concerns the gene SRC and nasopharyngeal carcinoma.